0001140361-20-006260.txt : 20200318
0001140361-20-006260.hdr.sgml : 20200318
20200318213212
ACCESSION NUMBER: 0001140361-20-006260
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200316
FILED AS OF DATE: 20200318
DATE AS OF CHANGE: 20200318
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Davis Katherine Lyon
CENTRAL INDEX KEY: 0001399265
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35569
FILM NUMBER: 20726269
MAIL ADDRESS:
STREET 1: C/O CHEMBIO DIAGNOSTICS
STREET 2: 3661 HORSEBLOCK ROAD
CITY: MEDFORD
STATE: NY
ZIP: 11763
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CHEMBIO DIAGNOSTICS, INC.
CENTRAL INDEX KEY: 0001092662
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 880425691
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 555 WIRELESS BLVD.
CITY: HAUPPAUGE
STATE: NY
ZIP: 11788
BUSINESS PHONE: (631) 924-1135
MAIL ADDRESS:
STREET 1: 555 WIRELESS BLVD.
CITY: HAUPPAUGE
STATE: NY
ZIP: 11788
FORMER COMPANY:
FORMER CONFORMED NAME: Chembio Diagnostics Inc.
DATE OF NAME CHANGE: 20040607
FORMER COMPANY:
FORMER CONFORMED NAME: TRADING SOLUTIONS COM INC
DATE OF NAME CHANGE: 19990805
4
1
form4.xml
FORM 4
X0306
4
2020-03-16
0001092662
CHEMBIO DIAGNOSTICS, INC.
CEMI
0001399265
Davis Katherine Lyon
555 WIRELESS BOULEVARD
HAUPPAUGE
NY
11788
true
Restricted Stock Units
2020-03-16
4
A
0
16314
0
A
Common Stock
16314
16314
D
Option to purchase
2.36
2020-03-16
4
A
0
36252
0
A
2027-03-15
Common Stock
36252
36252
D
Each restricted stock unit represents a contingent right to receive one share of Common Stock.
The restricted stock units are scheduled to vest in full immediately prior to the earlier to occur of (i) the 2021 annual meeting of stockholders of the issuer, and (ii) a Change in Control (as defined in the 2019 Omnibus Incentive Plan of the issuer).
The option is scheduled to vest and become exercisable in full immediately prior to the earlier to occur of (i) the 2021 annual meeting of stockholders of the issuer, and (ii) a Change in Control.
/s/ Mark L. Johnson, Attorney-in-Fact for Katherine Lyon Davis
2020-03-18